Form 4: H.B. Fuller Executive VP Acquires Stock Options and Restricted Stock Units
SEC Form 4
Nathan D. Weaver, Executive VP of Business Transformation at H.B. Fuller, reports acquisition of stock options and restricted stock units.
Summary
- On January 27, 2025, Nathan D. Weaver, Executive VP of Business Transformation at H.B. Fuller, filed a Form 4.
- The filing reports the acquisition of 14,844 employee stock options with an exercise price of $64.28, vesting in three annual installments starting January 27, 2026, and expiring on January 27, 2035.
- Weaver also acquired 2,599 restricted stock units, which convert into common stock on a 1-for-1 basis and vest in three annual installments starting January 27, 2026, and expiring on January 27, 2028.
- The filing also details Weaver's existing holdings of common stock, employee stock options at various exercise prices and vesting schedules, phantom units, and restricted stock units.
- The report was signed by Patrick J. Seul, Attorney-in-Fact, on January 29, 2025.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating insider transactions, which can be interpreted as a sign of confidence, but it doesn't provide strong positive or negative signals.
Positives
- The acquisition of stock options and restricted stock units by an executive could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions. They are closely watched by investors for signals about management's confidence in the company.
Comparison to Industry Standards
- Executive compensation packages, including stock options and restricted stock units, are common across publicly traded companies.
- The vesting schedules and exercise prices are typical for such grants, designed to incentivize long-term performance.
- Comparing the size of the grants and the vesting schedules to those of executives at comparable companies in the adhesives and sealants industry (e.g., Avery Dennison, 3M) would provide a more detailed assessment of the competitiveness of H.B. Fuller's compensation practices.
Stakeholder Impact
- The acquisition of stock options and restricted stock units by an executive could positively influence shareholder sentiment, reflecting confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 04/02/2021 | Date of employee stock option (Right-to-Buy) with an exercise price of $26.66 |
| 01/24/2023 | Date of employee stock option (Right-to-Buy) with an exercise price of $72.94 |
| 01/24/2024 | Date of employee stock option (Right-to-Buy) with an exercise price of $68.17 and restricted stock units |
| 01/26/2025 | Date of employee stock option (Right-to-Buy) with an exercise price of $77.72 |
| 01/27/2025 | Date of transaction for stock options and restricted stock units |
| 01/29/2025 | Date of signature by Attorney-in-Fact |
| 01/26/2026 | Vesting start date for some stock options and restricted stock units |
| 01/27/2026 | Vesting start date for some stock options and restricted stock units |
| 01/24/2027 | Expiration date for some restricted stock units |
| 01/26/2027 | Expiration date for some stock options |
| 01/27/2028 | Expiration date for some restricted stock units |
| 01/24/2029 | Expiration date for some stock options |
| 01/24/2030 | Expiration date for some stock options |
| 04/02/2030 | Expiration date for some stock options |
| 01/27/2031 | Expiration date for some stock options |
| 01/24/2032 | Expiration date for some stock options |
| 01/24/2033 | Expiration date for some stock options |
| 01/26/2034 | Expiration date for some stock options |
| 01/27/2035 | Expiration date for some stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.